Connect with us

National

Regulator approves Pfizer vaccine for all people over 16 – Korea Biomedical Review

The government on Friday officially authorized Pfizer’s coronavirus vaccine Comirnaty with 95 percent preventive efficacy and allowed its use for all people aged…

Published

on

Article feature image

The government on Friday officially authorized Pfizer’s coronavirus vaccine Comirnaty with 95 percent preventive efficacy and allowed its use for all people aged 16 or older.
The Ministry of Food and Drug Safety made the decision after having three separate evaluations on the vaccine’s efficacy and safety. People have to get two shots with the interval of three weeks.
Previously, adolescents under 18 were not included in the government’s vaccination plan because there is no domestically licensed…

Click here to view the original article.